STING1 and lung carcinoma: Recent studies have underscored the critical role of the cGAS-STING pathway in anti-tumor immunity, particularly in lung cancer, where its activation significantly enhances immune activity within the tumor microenvironment, thereby suppressing tumor growth and metastasis 8, 13.